Results 131 to 140 of about 91,557 (220)

Fragmentation of an In-Date Copper Intrauterine Device: An Unusual Complication. [PDF]

Cureus
Mamah J, Dube T, Aramabi E, Unwaha E, Dagba M.   +4 more
europepmc   +1 more source

Expanding long-acting contraceptive options: a prospective cohort study of the hormonal intrauterine device, copper intrauterine device, and implants in Nigeria and Zambia.

Lancet Glob Health, 2021
Brunie A, Stankevitz K, Nwala AA, Nqumayo M, Chen M, Danna K, Afolabi K, Rademacher KH.   +7 more
europepmc   +1 more source

Changing trends in the usage of copper intrauterine contraceptive device: a five year institutional study

, 2017
J. C. Malavika, Prema Prabhudev
openalex   +2 more sources

Classic versus uterine sound-sparing approach for insertion of copper T380A intrauterine device: A randomized clinical trial

, 2017
Mohammed K. Ali, Ahmed M. Abbas, Osama S. Abdalmageed, Tarek Farghaly, Ali Yosef   +4 more
openalex   +1 more source

Contraception with levonorgestrel-releasing intrauterine system versus copper intrauterine device: a meta-analysis of randomized controlled trials. [PDF]

EClinicalMedicine
Liu P, Meng J, Xiong Y, Wu Y, Xiao Y, Gao S.   +5 more
europepmc   +1 more source

A premenopausal woman with fragmentation of a nonexpired copper intrauterine device and concomitant presence of Actinomyces species. [PDF]

Proc (Bayl Univ Med Cent)
Sprong B, Schwab G, Titus SJ.
europepmc   +1 more source

Perinatal outcomes with a copper intrauterine device in situ after 28 gestational weeks: A retrospective study of sole center in southeast China. [PDF]

Medicine (Baltimore)
Chen X, Zhao B.
europepmc   +1 more source

Faculty Opinions recommendation of HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial.

, 2019
John K. Amory
openalex   +2 more sources

Sexual behaviour among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: Data from the ECHO randomized trial. [PDF]

PLoS One
Hofmeyr GJ, Singata-Madliki M, Batting J, Steyn P, Thomas KK, Issema R, Beesham I, Mbatsane E, Morrison C, Deese J, Smit J, Philip N, Palanee-Phillips T, Reddy K, Onono M, Mastro TD, Baeten JM, Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium.   +17 more
europepmc   +1 more source

Comparison of pregnancy incidence among African women in a randomized trial of intramuscular depot medroxyprogesterone acetate (DMPA-IM), a copper intrauterine device (IUDs) or a levonorgestrel (LNG) implant for contraception. [PDF]

Contracept X, 2020
Onono M, Nanda K, Heller KB, Taylor D, Yacobson I, Heffron R, Kasaro MP, Louw CE, Nhlabasti Z, Palanee-Phillips T, Smit J, Wakhungu I, Gichangi PB, Mugo NR, Morrison C, Baeten JM, Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium.   +16 more
europepmc   +1 more source